Membranoproliferative glomerulonephritis type II (dense deposit disease) in association with monoclonal gammopathy

Nephrology

Volumn 12, Issue 4, 2007, Pages 419-420

  Hill, Prue A ^a   Desmond, Michael ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MONOCLONAL IMMUNOGLOBULINEMIA; NEPHROTIC SYNDROME; NEUTROPENIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; MALE; PARAPROTEINEMIAS;

EID: 34447564894     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00807.x     Document Type: Article

References (5)

1. Appel GB, Cook T, Hageman G et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): An update. J. Am. Soc. Nephrol. 2005 16 : 1392 403.
2. Hill PA, Crikis S, Goodman DG. A 65-year-old man with early renal allograft dysfunction. Am. J. Kidney Dis 2003 42 : 207 11.
3. Goodship GH. Factor H genotype-phenotype correlations: Lessons from aHUS, MPGN II, and AMD. Kidney Int. 2006 70 : 12 3.
4. Meri S, Koistinen V, Miettinen A et al. Activation of the alternative pathway of complement by monoclonal λ light chains in membranoproliferative glomerulonephritis. J. Exp Med. 1992 175 : 939 50.
5. Jokiranta TS, Solomon A, Pangburn MK et al. Nephritogenic λ light chain dimer: a unique human miniautoantibody against complement factor H. J. Immunol. 1999 163 : 4590 96.